Russell Caprioli, DPM
Podiatrist · Valley Stream, NYNPI 1679507792
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,622 of the $7,675 with a category attached, or 60.2%. 20 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 30.2% of the total. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $85.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$2K
- Osteomed LLC$2K
- Smith+Nephew$924
- Stryker$803
- Polynovo North America LLC$679
- DJO, LLC$240
- plus $1K from 14 others
What the payments were for
- Speaking & faculty fees$1,50020%
- Travel & lodging$1,35218%
- Food & beverage$4,62260%
- Education$1051%
- Gifts$961%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 13 | $2,316 |
| Osteomed LLC | 3 | $1,635 |
| Smith+Nephew | 29 | $924 |
| Stryker(2 entities) | 7 | $803 |
| Polynovo North America LLC | 4 | $679 |
| DJO, LLC | 3 | $240 |
| Organogenesis Inc. | 1 | $150 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $147 |
| Baxter Healthcare | 2 | $138 |
| Acera Surgical, Inc. | 1 | $120 |
| Bioventus LLC | 6 | $109 |
| Kerecis Limited | 2 | $94 |
| Acumed LLC | 1 | $78 |
| Integra Lifesciences Corporation | 3 | $71 |
| Sandoz | 2 | $45 |
| Zimmer Biomet | 1 | $41 |
| Averitas Pharma Inc. | 1 | $38 |
| AbbVie | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $15 |
| Paragon 28, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXT-Encompass$1,500
- EXT-Extremilock Foot$1,500
- EXT-ExtremiLock Ankle$1,500
- EXT-Staple$1,500
- EXT-ExtremiFix Midsize/Large$1,500
- Lapiplasty$680
- Novosorb BTM$679
- LAPIPLASTY SYSTEM 1$423
- TMC NANOPLASTY SYSTEM$249
- Stravix$232
- CITREFIX$222
- Lapiplasty System$168
- PuraPly$150
- 7 X 23MM CITRELOCK IMPLANT$143
- FLEXBAND MULTI KIT XL$143
- CARTIVA$143
- PROPHECY$140
- Restrata Wound Matrix$120
- Grafix$113
- GrafixPL$113
How this compares
$7,675 in reported general payments places this provider in the 90th percentile of 862 podiatrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 40 | $34,020 |
| Tavaborole | 45 | $18,015 |
| SantylCollagenase Clostridium Hist. | 12 | $6,898 |
| Ketoconazole | 61 | $1,789 |
| Doxycycline Monohydrate | 50 | $553 |
| Mupirocin | 84 | $398 |
| Gabapentin | 80 | $361 |
| Ammonium Lactate | 22 | $265 |
| Doxycycline Hyclate | 30 | $228 |
| Meloxicam | 19 | $160 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $153 |
| Ibuprofen | 35 | $150 |
| Levofloxacin | 26 | $150 |
| Cefadroxil | 18 | $120 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $13 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $147 | $34,02040 claims |
| Smith+NephewSantyl | $924 | $6,89812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 862 podiatrist providers in New York.
Other podiatrist in Valley Stream
- Christopher BromleyPoughkeepsie$152K
- Scott GawlikBrooklyn$77K
- Waldemar MajdanskiAstoria$71K
- Michael HutzelSeaford$64K
- Donald RubinCorning$53K
- Steven NormanMiddle Village$42K
- Elvis DanneNew York$35K
- Adam CirlincioneGlen Cove$31K
- Jude ViolanteNiagara Falls$30K
- Ammar Al RubaiayNew Hyde Park$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.